Eric Helmer
Galapagos (France)(FR)Certara (United States)(US)GlaxoSmithKline (Italy)(IT)Galapagos (Netherlands)(NL)Galapagos (Belgium)(BE)
Publications by Year
Research Areas
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Reproductive System and Pregnancy, Pregnancy and Medication Impact, Pharmacogenetics and Drug Metabolism, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study(2017)381 cited
- → First‐in‐human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL‐17A and IL‐17F, in mild psoriasis(2016)140 cited
- → Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis(2023)106 cited
- → A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren’s syndrome(2020)45 cited
- → Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials(2019)42 cited
- → GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial(2022)37 cited